Imprimis Pharmaceuticals, Inc. (IMMY) - NASDAQ
  • Ian Cassel | Send Message 31 Mar

    Members turned over ten more rocks in March $IMMY $RSSS $SMDM $NTE.V $SILC $VASO $VLE.TO $IGG.TO $EDGE $AXTI
      • Michael Blake Kuritz | Send Message 20 Jan

        Mid-Stage Companies Have Huge Lupus Potential $ANTH, $AUPH, $IMMY
          • Singular Research | Send Message 14 Dec 2015

            RTRX - Generic Threats Spell Trouble $RTRX, $IMMY, $ESRX
              • Don Dion | Send Message 2 Dec 2015

                Novartis Comes Under Fire: Consider Newer Startup Imprimis Instead $IMMY
                  • SakuraSFA2 | Send Message 23 Oct 2015

                    Imprimis Pharmaceuticals Inc.: The "Anti-Turing Pharmaceuticals" $IMMY, $VRX
                      • noobie107 | Send Message 22 Oct 2015

                        $IMMY introduces a competitor to Turing's Daraprim for $1/pill.
                          • From The Floor | Send Message 5 Apr 2013

                            SELL ($IMMY)
                              Company Description
                              Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and... More
                              Sector: Healthcare
                              Industry: Biotechnology
                              Country: United States